Javascript must be enabled to continue!
Cost Effectiveness of Defibrillation by Targeted Responders in Public Settings
View through CrossRef
Background—
Out-of-hospital cardiac arrest is frequent and has poor outcomes. Defibrillation by trained targeted nontraditional responders improves survival versus historical controls, but it is unclear whether such defibrillation is a good value for the money. Therefore, this study estimated the incremental cost effectiveness of defibrillation by targeted nontraditional responders in public settings by using decision analysis.
Methods and Results—
A Markov model evaluated the potential cost effectiveness of standard emergency medical services (EMS) versus targeted nontraditional responders. Standard EMS included first-responder defibrillation followed by advanced life support. Targeted nontraditional responders included standard EMS supplemented by defibrillation by trained lay responders. The analysis adopted a US societal perspective. Input data were derived from published or publicly available data. Future costs and effects were discounted at 3%. Monte Carlo simulation and sensitivity analyses assessed the robustness of results. Standard EMS had a median of 0.47 (interquartile range [IQR]=0.32 to 0.69) quality-adjusted life years and a median of $14 100 (IQR=$8600 to $21 900) costs per arrest. Targeted nontraditional responders in casinos had an incremental cost of a median $56 700 (IQR=$44 100 to $77 200) per additional quality-adjusted life year. The results were sensitive to changes in time to defibrillation, incidence of arrest, and number of devices required to implement rapid defibrillation.
Conclusions—
Where cardiac arrest is frequent and response time intervals are short, rapid defibrillation by targeted nontraditional responders may be a good value for the money compared with standard EMS. The incidence of arrest should be considered when choosing locations to implement public access defibrillation.
Ovid Technologies (Wolters Kluwer Health)
Title: Cost Effectiveness of Defibrillation by Targeted Responders in Public Settings
Description:
Background—
Out-of-hospital cardiac arrest is frequent and has poor outcomes.
Defibrillation by trained targeted nontraditional responders improves survival versus historical controls, but it is unclear whether such defibrillation is a good value for the money.
Therefore, this study estimated the incremental cost effectiveness of defibrillation by targeted nontraditional responders in public settings by using decision analysis.
Methods and Results—
A Markov model evaluated the potential cost effectiveness of standard emergency medical services (EMS) versus targeted nontraditional responders.
Standard EMS included first-responder defibrillation followed by advanced life support.
Targeted nontraditional responders included standard EMS supplemented by defibrillation by trained lay responders.
The analysis adopted a US societal perspective.
Input data were derived from published or publicly available data.
Future costs and effects were discounted at 3%.
Monte Carlo simulation and sensitivity analyses assessed the robustness of results.
Standard EMS had a median of 0.
47 (interquartile range [IQR]=0.
32 to 0.
69) quality-adjusted life years and a median of $14 100 (IQR=$8600 to $21 900) costs per arrest.
Targeted nontraditional responders in casinos had an incremental cost of a median $56 700 (IQR=$44 100 to $77 200) per additional quality-adjusted life year.
The results were sensitive to changes in time to defibrillation, incidence of arrest, and number of devices required to implement rapid defibrillation.
Conclusions—
Where cardiac arrest is frequent and response time intervals are short, rapid defibrillation by targeted nontraditional responders may be a good value for the money compared with standard EMS.
The incidence of arrest should be considered when choosing locations to implement public access defibrillation.
Related Results
Left atrioventricular coupling index in cardiac resynchronization therapy responders and non-responders
Left atrioventricular coupling index in cardiac resynchronization therapy responders and non-responders
Abstract
Background
The left atrioventricular coupling index (LACI) is a novel imaging metric, providing insight into the relati...
CONTINUOUS COMPRESSION WITHOUT DEFIBRILLATION FAVOURED NO SHORT-TERM SURVIVAL IN PROLONGED VENTRICULAR FIBRILLATION
CONTINUOUS COMPRESSION WITHOUT DEFIBRILLATION FAVOURED NO SHORT-TERM SURVIVAL IN PROLONGED VENTRICULAR FIBRILLATION
Objectives
Aims: During the 2005 American Heart Association (AHA) Consensus Conference, compression first versus defibrillation first for sudden cardiac arrest wi...
Clopidogrel response variability and its correlation with recurrent cardiovascular events in Chinese patients undergoing percutaneous coronary intervention
Clopidogrel response variability and its correlation with recurrent cardiovascular events in Chinese patients undergoing percutaneous coronary intervention
Objective
The present study was designed to explore response variability and its correlation with recurrent cardiovascular events in Chinese patients undergoing P...
A STUDY OF THIAMINE DEFICIENCY IN PATIENTS WITH ACUTE ONSETENCEPHALOPATHY
A STUDY OF THIAMINE DEFICIENCY IN PATIENTS WITH ACUTE ONSETENCEPHALOPATHY
Introduction:Vitamin B1, also known as thiamine, and its crucial role in energy metabolism and proper functioning of the nervous and cardiovascular systems. Thiamine is an essentia...
GW24-e1013 ZP123 reduces energy required for defibrillation by preventing connexin43 remodeling during prolonged ventricular fibrillation in swine
GW24-e1013 ZP123 reduces energy required for defibrillation by preventing connexin43 remodeling during prolonged ventricular fibrillation in swine
Objectives
In ventricular fibrillation, the uncoupling of gap junctions slows conduction velocity and increases action-potential dispersion, which slows and dimin...
Clinical and molecular characteristics of responders versus non-responders to immune checkpoint inhibitors (ICI) in NSCLC.
Clinical and molecular characteristics of responders versus non-responders to immune checkpoint inhibitors (ICI) in NSCLC.
114 Background: Evidence from randomized clinical trials and retrospective studies has shown that tumors with specific driver mutations may be less likely to respond to ICI; the o...
ONE-SHOCK VERSUS CONTINUOUS DEFIBRILLATION IN AN 8-MIN VENTRICULAR FIBRILLATION CANINE MODEL OF CARDIAC ARREST
ONE-SHOCK VERSUS CONTINUOUS DEFIBRILLATION IN AN 8-MIN VENTRICULAR FIBRILLATION CANINE MODEL OF CARDIAC ARREST
Objectives
To investigate the resuscitation effect of a one-shock defibrillation protocol versus conventional continuous defibrillation with treatment variation i...
The incidence of cardiac arrest requiring defibrillation and defibrillation protocols in Australasian hyperbaric units
The incidence of cardiac arrest requiring defibrillation and defibrillation protocols in Australasian hyperbaric units
Introduction: Cardiac arrest (CA) during hyperbaric oxygen treatment (HBOT) is exceedingly rare with only a few cases reported. It is unknown if in-chamber defibrillation of a pati...

